SEC
SlamSEC
SearchBrowseEarnings

Valneva SE

Nasdaq:VALN
Biological Products, (No Diagnostic Substances)·SAINT-HERBLAIN, I0
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(248 total)

TypeDateAccessionPeriodSize
6-K
Mar 18, 2026
0001628280-26-0191596-K
Dec 31, 2026
117.3 KB
20-F
Mar 17, 2026
0001628280-26-01880820-F
Dec 31, 2025
54.2 MB
SCHEDULE 13D/A
Mar 10, 2026
0001104659-26-025806
—
58.5 KB
6-K
Mar 9, 2026
0001628280-26-0158826-K
Dec 31, 2026
24.7 KB
6-K
Mar 2, 2026
0001628280-26-0130746-K
Dec 31, 2026
27.4 KB
6-K
Feb 19, 2026
0001628280-26-0094636-K
Dec 31, 2026
47.4 KB
6-K
Feb 13, 2026
0001628280-26-0079736-K
Dec 31, 2026
29.7 KB
6-K
Feb 3, 2026
0001628280-26-0048146-K
Dec 31, 2026
41.4 KB
6-K
Jan 20, 2026
0001628280-26-0025116-K
Dec 31, 2026
34.8 KB
6-K
Jan 9, 2026
0001628280-26-0014846-K
Dec 31, 2026
23.5 KB
6-K
Dec 31, 2025
0001628280-25-0591806-K
Dec 31, 2025
35.8 KB
6-K
Dec 11, 2025
0001628280-25-0564176-K
Dec 31, 2025
46.7 KB
6-K
Nov 28, 2025
0001628280-25-0542226-K
Dec 31, 2025
26.5 KB
6-K
Nov 26, 2025
0001628280-25-0540696-K
Dec 31, 2025
96.3 KB
6-K
Nov 20, 2025
0001836564-25-0000206-K
Sep 30, 2025
1.3 MB
6-K
Nov 4, 2025
0001628280-25-0485156-K
Dec 31, 2025
33.9 KB
6-K/A
Oct 6, 2025
0001836564-25-0000186-K/A
Dec 31, 2025
43.4 KB
6-K
Oct 6, 2025
0001628280-25-0442606-K
Dec 31, 2025
42.9 KB
6-K
Oct 6, 2025
0001628280-25-0442506-K
Dec 31, 2025
40.3 KB
SCHEDULE 13D/A
Sep 5, 2025
0001104659-25-087815
—
54.3 KB
6-K
Sep 3, 2025
0001836564-25-0000146-K
Dec 31, 2025
45.3 KB
6-K
Aug 25, 2025
0001836564-25-0000116-K
Dec 31, 2025
40.5 KB
6-K
Aug 18, 2025
0001836564-25-0000096-K
Dec 31, 2025
41.0 KB
6-K
Aug 12, 2025
0001628280-25-0397896-K
Jun 30, 2025
6.5 MB
6-K
Aug 7, 2025
0001628280-25-0386156-K
Dec 31, 2025
36.7 KB
25 filings shown

Valneva SE is a specialty vaccine company registered in Saint-Herblain, France, developing, producing and commercializing vaccines for infectious diseases. It has manufacturing sites in Livingston, Scotland; Solna, Sweden, and Vienna, Austria; with other offices in France, Canada and the United States.